115
Views
23
CrossRef citations to date
0
Altmetric
Original Paper

New pharmacological strategies to restore hearing and treat tinnitus

, &
Pages 411-415 | Received 01 Sep 2003, Accepted 11 Sep 2003, Published online: 08 Jul 2009
 

Abstract

Recent advances in molecular pharmacology of the cochlea have lead to a much better understanding of the physiology, and especially the pathophysiology, of the sensorineural structures of the organ of Corti. Knowledge of the intimate molecular mechanisms of cellular dysfunction is of considerable use in the development of new therapeutic strategies. Herein, we summarize the mechanisms of sensory hair cell death after various injuries. Based on these molecular mechanisms, we propose novel therapeutic strategies to restore hearing. In addition to permanent hearing loss, exposure to noise or ototoxic drugs also induces tinnitus. We thus review recent findings obtained from a behavioral model of tinnitus in rats. In addition to providing evidence for the site and mechanism of generation of tinnitus induced by salicylate, these results support the idea that targeting cochlear N-methyl-D-aspartate receptors may represent a promising therapeutic strategy for treating tinnitus.

Guitton MJ, Wang J, Puel J-L. New pharmacological strategies to restore hearing and treat tinnitus. Acta Otolaryngol 2004; 124: 411–415.

Guitton MJ, Wang J, Puel J-L. New pharmacological strategies to restore hearing and treat tinnitus. Acta Otolaryngol 2004; 124: 411–415.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.